Introduction
============

Gastritis is an inflammation of the stomach and has a high incidence in adults ([@B1]). It caused by multiple factors such as *Helicobacter pylori* (*H. pylori*), autoimmune problems, non-steroidal anti-inflammatory medicine, bile reflux, pernicious anemia, alcohol consumption, smoking and other diseases and conditions such as Crohn's disease and HIV/AIDS. But the main reason for chronic gastritis is *H. pylori* infection ([@B2]).

*H. pylori* is a Gram-negative bacteria with strong association with upper gastrointestinal diseases such as peptic ulcer diseases (gastric ulcer, duodenal ulcer) and malignancies (gastric cancer, lymphoma), reported worldwide and in Iran ([@B3], [@B4]). At least half of the world's population is infected by the *H. pylori*, making it the most widespread infection in the world ([@B5]). The acute infection rate of *H. pylori* varies by region. However, *H. pylori* infection is highly prevalent in Asia and developing countries, and multifocal atrophic gastritis (intestinal metaplasia) and gastric adenocarcinomas are more common in these areas ([@B6], [@B7]). The incidence of *H. pylori* is 3-10% of the population every year in developing countries, as compared to 0.5% in developed countries ([@B8]). The age at which this bacterium is acquired seems to influence the possible pathologic outcome of the infection: people infected with it at an early age are likely to develop more intense inflammation that may be followed by atrophic gastritis with a higher subsequent risk of gastric ulcer, gastric cancer, or both ([@B9], [@B10]). Acquisition at an older age brings different gastric changes that are more likely to result in duodenal ulcer ([@B11]). Infections are usually acquired in early childhood in all countries. However, the infection rate of children in developing nations is higher than in industrialized nations, probably due to poor sanitary conditions, perhaps combined with lower antibiotics usage for unrelated pathologies ([@B12], [@B13]). In developed nations, it is currently uncommon to find infected children, but the percentage of infected people increases with age, with about 50% infected for those over the age of 60 compared with around 10% between 18 and 30 years ([@B14]).

*H. pylori* cause chronic active inflammation of the gastric mucosa in the majority of infected patients. In a considerable number of them, this will eventually lead to a loss of gastric glands, and thus the establishment of atrophic gastritis ([@B15]). This is associated with the development of intestinal metaplasia and dysplasia ([@B16]). These consecutive conditions increase the risk for gastric cancer particularly of the intestinal type ([@B17]-[@B19]). In accordance with this point of the view, the main objectives of this study are to investigate the prevalence rate of H*. pylori* infection and the presence of intestinal metaplasia among endoscopic patients at Taleghani Hospital, according to age across gender.

Patients and Methods
====================

All data for this cross-sectional study were collected from medical records of 14,860 patients suspected of gastritis, who were referred to the department of gastrointestinal of Tehran's Taleghani Hospital between the years 2008 to 2014 in Iran. All these patients were suspected of gastritis. Therefore, undergoing endoscopic and biopsy they were assessed for gastritis, H*. pylori*and intestinal metaplasia. Finally, we examined the time trend of H*. pylori*prevalence and presence of intestinal metaplasia over the period of seven years in gastritis and non-gastritis patients according to the gender and age groups. The patients were divided into 6 age groups (16-30, 30-40, 40-50, 50-60, 60-70 and \>70 years). In addition, these groups were further divided into three minor groups namely young adults (16-40), older adults (40-60) and geriatric group (\>60) years.

**Statistical Analysis**

Data were entered and analyzed using statistical package for social sciences (SPSS) for windows version 21 software (IBM Inc., Chicago, IL, USA). Descriptive statistics and frequency distribution such as mean, standard deviation and percentage were employed. The chi-square test was used to compare the qualitative variables. P\< 0.05 was considered as statistically significant.

Results
=======

A total of 14,860 patients with a mean age of 48±16.8 (± standard deviation) years old were enrolled in this cross-sectional study and 6953 (46.8%) patients were male. The ranges of the age of patients were 16-93 years.

A diagnosis of gastritis was established in 13,552 patients, representing approximately (91.2%) of all cases.

###### 

Gastritis rates according to gender, age and years

  ----------------------------------------------------------------
                Gastritis                                 
  ------------- ----------- ------------- --------------- --------
  Gender        Male\       657 (9.4)\    6296 (90.6)\    6953\
                Female      651 (8.2)     7258 (91.8)     7907

  H*. pylori*   No\         296 (12.1)\   2158 (87.9)\    2454\
                Yes         1012 (8.2)    11394 (91.8)    12406

  Intestinal\   No\         1104 (8.9)\   11364 (91.1)\   12471\
  metaplasia    Yes         204 (8.5)     2185 (91.5)     2389

  Age group     16-30\      233 (8.6)\    2492 (91.4)\    2725\
                30-40\      216 (8.7)\    2253 (91.3)\    2469\
                40-50\      209 (7.8)\    2482 (92.2)\    2691\
                50-60\      253 (9.2)\    2495 (90.8)\    2748\
                60-70\      161 (8.7)\    1697 (91.3)\    1858\
                \>70        139 (9.2)     1365 (90.8)     1504

  Years         2008\       249 (14.5)\   1466 (85.5)\    1715\
                2009\       204 (10.7)\   1694 (89.3)\    1898\
                2010\       279 (8.5)\    3021 (91.5)\    3300\
                2011\       149 (5.0)\    2804 (95.0)\    2953\
                2012\       249 (8.9)\    2536 (91.1)\    2785\
                2013\       108 (9.6)\    1020 (90.4)\    1128\
                2014        70 (6.5)      1011 (93.5)     1081
  ----------------------------------------------------------------

###### 

H*. pylori* rates according to gender, age and years

  -----------------------------------------------------------------------
  **H** ***. pylori***                                           
  ---------------------- -------- -------------- --------------- --------
  **Gender**             Male\    1167 (16.8)\   5786 (83.2)\    6953\
                         Female   1287 (16.3)    6620 (83.7)     7907

  **Gastritis**          No\      296 (22.6)\    1012 (77.4)\    1308\
                         Yes      2158 (15.9)    11394 (84.1)    13552

  **Intestinal**\        No\      1840 (14.8)\   10631 (85.2)\   12471\
  **metaplasia**         Yes      614 (22.7)     1775 (74.3)     2389

  **Age group**          16-30\   435 (16.0)\    2290 (84.0)\    2725\
                         30-40\   389 (15.8)\    2080 (84.2)\    2469\
                         40-50\   456 (16.9)\    2235 (83.1)\    2691\
                         50-60\   506 (18.4)\    2242 (81.6)\    2748\
                         60-70\   339 (18.2)\    1519 (81.8)\    1858\
                         \>70     268 (17.8)     1236 (82.2)     1504

  **Years**              2008\    117 (6.8)\     1598 (93.2)\    1715\
                         2009\    119 (6.3)\     1779 (93.7)\    1898\
                         2010\    108 (3.3)\     3192 (96.7)\    3300\
                         2011\    157 (5.3)\     2796 (94.7)\    2953\
                         2012\    1265 (45.4)\   1520 (54.6)\    2785\
                         2013\    302 (26.8)\    826 (73.2)\     1128\
                         2014     386(35.7)      695 (64.3)      1081
  -----------------------------------------------------------------------

###### 

Intestinal metaplasia rates according to gender, age and years

  --------------------------------------------------------------------------
  **Intestinal metaplasia**                                          
  --------------------------- -------- -------------- -------------- -------
  Gender                      Male\    5779 (83.1)\   1174 (16.9)\   6953\
                              Female   6692 (84.5)    1215 (15.4)    7907

  Gastritis                   No\      1104 (84.4)\   204 (15.6)\    1308\
                              Yes      11367 (83.9)   2185 (16.1)    13552

  H*. pylori*                 No\      1840 (75.0)\   614 (25.0)\    2454\
                              Yes      10631 (85.7)   1775 (14.3)    12406

  Age group                   16-30\   2462 (90.3)\   263 (9.7)\     2725\
                              30-40\   2195 (88.9)\   274 (11.1)\    2469\
                              40-50\   2304 (85.6)\   397 (14.4)\    2691\
                              50-60\   2276 (82.8)\   472 (17.2)\    2748\
                              60-70\   1441 (77.6)\   4171 (22.4)\   1858\
                              \>70     1066 (70.9)    438 (29.1)     1504

  Years                       2008\    1380 (80.5)\   335 (19.5)\    1715\
                              2009\    1552 (81.8)\   346 (19.5)\    1898\
                              2010\    2894 (87.7)\   406 (12.3)\    3300\
                              2011\    2391 (81.0)\   582 (19.0)\    2953\
                              2012\    2355 (84.6)\   430 (15.4)\    2785\
                              2013\    963 (85.4)\    165 (14.6)\    1128\
                              2014     936 (86.6)     145 (13.4)     1081
  --------------------------------------------------------------------------

Gastritis patients detected as mild with 4,479 (30.1%), moderate with 7,430 (50.0%) and severe form with 1,643 (11.1%). There was no association between gastritis and sex. Gastritis was present alike in almost age groups and in during the 7 years. [Table 1](#T1){ref-type="table"} shows the situation of gastritis according to the gender, various ages and years.

The overall prevalence of *H. pylori* infection in this study was 83.5% (12406/14860), we also found the strong association (*P*\<0.05) between H*. pylori* infection and gastritis with 84.1% (11,394/13,552) prevalence of H*. pylori* infection in gastritis patients. The prevalence rate of H*. pylori*among patient with severe gastritis was significantly higher (*P*\<0.05), compared to mild and moderate gastritis. The prevalence of H*. pylori* infection decreased with age and it has also declined in recent years (*P*\<0.05). [Table 2](#T2){ref-type="table"} shows the prevalence rate of H*. pylori*according to the gender, various age and years.

Totally, the presence of intestinal metaplasia in these patients was 2389, representing approximately (16.1%). The rate of intestinal metaplasia was significantly higher (*P*\<0.05) in H*. pylori* infected patients. Besides it was significantly (*P*\<0.05) more common in severe gastritis patients. The age range further categorized into 3 groups including: young adults (16-40), older adults (40-60) and geriatric (\>60 years). The rate of intestinal metaplasia increased with age. The rate among geriatric groups (\>60 year) was significantly (*P*\<0.05) higher than younger and older adults. Also, intestinal metaplasia has been decreased through these years. [Table 3](#T3){ref-type="table"} shows the presence of intestinal metaplasia according to the gender, various ages and years.

Discussion
==========

In this study, the prevalence of H*. pylori*infection and presence of intestinal metaplasia was determined among the Iranian population, indicating that the prevalence of H*. pylori*infection is still high among Iranian patients. However, its rate is slightly declining through recent years.

Several studies have reported different prevalence rate of H*. pylori*infection between countries ([@B20], [@B21]), which might be due to diverse contributing factors including socioeconomic status, geographical or living conditions, as well as ethnicity or location of each population ([@B3], [@B22]).

Similar to several studies from Asia and Middle East including China, South Korea, Iran, and Kuwait, our research showed that the prevalence of *H. pylori* has declined in recent years ([@B21], [@B23]-[@B26]), which might be related to the human host factors as well as socioeconomic and hygiene factors ([@B27]). It appears that acquisition and transmission of *H. pylori* can be prevented to a large extent by following improved hygienic practices and standard of living ([@B28]). In all participants in this study, the prevalence of H*. pylori* was 83.5%, and also the prevalence rate of H*. pylori*infection only in gastritis patients was 84.1%, which was similar to some other studies that reported the H*. pylori*infection prevalence in Shiraz, Ardebil and north of Iran more than 85% ([@B4],[@B6], [@B29]). We analyzed the presence of H*. pylori*infection among patients with different ages and found that the prevalence of H*. pylori*infection decreased with age as similar as other studies ([@B30]) However, several studies showed that the prevalence of H*. pylori*infection increased with age in developing and developed countries ([@B31]-[@B33]).

Intestinal metaplasia represents a phenotypic change from the normal epithelial cells of the gastric mucosa to an intestinal phenotype ([@B30], [@B34]). It is considered to be an advanced stage of atrophy because the original glands are replaced by metaplastic glands and chronologically, the metaplastic glands appear after the gastric glands are lost ([@B35]-[@B37]). In the present study, the percent of intestinal metaplasia was 16.1% and also the presence of intestinal metaplasia in patients with H*. pylori*infection was 14.3%. Based on our results, the presence of intestinal metaplasia has been declined in recent years, but in contrast with H*. pylori*infection, the prevalence of intestinal metaplasia increased with age. In this study we just presented the data of patients upper 16 years old because patients lower than 16 years did not undergo endoscopic in Taleghani Hospital. Therefore, further research should be done to find the rate and prevalence of H*. pylori*infection in Iranian children and provide a full spectrum of this infection for Iranian population.
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